Trial Outcomes & Findings for Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer (NCT NCT03223753)

NCT ID: NCT03223753

Last Updated: 2026-07-24

Results Overview

PCI is calculated in beats per meter from the average heart rate during the walking test minus the resting heart rate divided by meters walked per minute. Differences in PCI will be compared between groups at 24 weeks, the end of the intervention. Intent to treat analysis of variance (either transforming the data or employing a non-parametric equivalent if the data are not normally distributed) controlling for the stratification factors (sex, age, and treatment related risk group) will be used for comparison. General linear mixed models will be utilized to evaluate the effects of group assignment on changes in PCI over time to account for repeated measures on individual children, and for potential random effects such as original treating institution. Changes from baseline will be estimated as differences between model-based least squares means at specified time points (e.g., 24 weeks minus baseline) derived from the mixed model.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

299 participants

Primary outcome timeframe

Baseline and 24 weeks

Results posted on

2026-07-24

Participant Flow

Recruitment period: 08/14/2017-1/10/2025; first enrollment 11/29/2017, last enrollment 4/26/2024. 118 COG sites opened the protocol, with 66 enrolling 1 or more participant in clinic.

Enrollment and randomization occurred concurrently.

Participant milestones

Participant milestones
Measure
Arm I (Tracking Device, Limited Version of Device)
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the limited version of device app/website to get basic information related to their physical activity for 6 months.
Arm II (Tracking Device, Interactive-reward Based Device)
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the full version of the interactive-reward based device app/website to see their activity, earn activity points, see other's activity, and interact with other patients for 6 months.
Overall Study
STARTED
147
152
Overall Study
COMPLETED
121
115
Overall Study
NOT COMPLETED
26
37

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm I (Tracking Device, Limited Version of Device)
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the limited version of device app/website to get basic information related to their physical activity for 6 months.
Arm II (Tracking Device, Interactive-reward Based Device)
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the full version of the interactive-reward based device app/website to see their activity, earn activity points, see other's activity, and interact with other patients for 6 months.
Overall Study
Lost to Follow-up
1
3
Overall Study
Physician Decision
0
2
Overall Study
Withdrawal by Subject
13
20
Overall Study
Ineligible
3
2
Overall Study
Relapsed
7
10
Overall Study
Withdrew Consent
2
0

Baseline Characteristics

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Total
n=299 Participants
Total of all reporting groups
Arm I (Tracking Device, Limited Version of Device)
n=147 Participants
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the limited version of device app/website to get basic information related to their physical activity for 6 months.
Arm II (Tracking Device, Interactive-reward Based Device)
n=152 Participants
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the full version of the interactive-reward based device app/website to see their activity, earn activity points, see other's activity, and interact with other patients for 6 months.
Age, Categorical
<=18 years
299 Participants
n=267 Participants
147 Participants
n=9 Participants
152 Participants
n=27 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=267 Participants
0 Participants
n=9 Participants
0 Participants
n=27 Participants
Age, Categorical
>=65 years
0 Participants
n=267 Participants
0 Participants
n=9 Participants
0 Participants
n=27 Participants
Age, Continuous
8.5 years
STANDARD_DEVIATION 2.7 • n=267 Participants
8.6 years
STANDARD_DEVIATION 2.6 • n=9 Participants
8.5 years
STANDARD_DEVIATION 2.7 • n=27 Participants
Sex: Female, Male
Female
101 Participants
n=267 Participants
42 Participants
n=9 Participants
59 Participants
n=27 Participants
Sex: Female, Male
Male
198 Participants
n=267 Participants
105 Participants
n=9 Participants
93 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=267 Participants
0 Participants
n=9 Participants
0 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=267 Participants
0 Participants
n=9 Participants
0 Participants
n=27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
299 Participants
n=267 Participants
147 Participants
n=9 Participants
152 Participants
n=27 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
n=267 Participants
1 Participants
n=9 Participants
2 Participants
n=27 Participants
Race (NIH/OMB)
Asian
18 Participants
n=267 Participants
7 Participants
n=9 Participants
11 Participants
n=27 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
n=267 Participants
1 Participants
n=9 Participants
1 Participants
n=27 Participants
Race (NIH/OMB)
Black or African American
40 Participants
n=267 Participants
17 Participants
n=9 Participants
23 Participants
n=27 Participants
Race (NIH/OMB)
White
199 Participants
n=267 Participants
102 Participants
n=9 Participants
97 Participants
n=27 Participants
Race (NIH/OMB)
More than one race
6 Participants
n=267 Participants
3 Participants
n=9 Participants
3 Participants
n=27 Participants
Race (NIH/OMB)
Unknown or Not Reported
31 Participants
n=267 Participants
16 Participants
n=9 Participants
15 Participants
n=27 Participants

PRIMARY outcome

Timeframe: Baseline and 24 weeks

Population: All randomized participants were included in the analysis (intention-to-treat approach). Missing values were imputed with group means.

PCI is calculated in beats per meter from the average heart rate during the walking test minus the resting heart rate divided by meters walked per minute. Differences in PCI will be compared between groups at 24 weeks, the end of the intervention. Intent to treat analysis of variance (either transforming the data or employing a non-parametric equivalent if the data are not normally distributed) controlling for the stratification factors (sex, age, and treatment related risk group) will be used for comparison. General linear mixed models will be utilized to evaluate the effects of group assignment on changes in PCI over time to account for repeated measures on individual children, and for potential random effects such as original treating institution. Changes from baseline will be estimated as differences between model-based least squares means at specified time points (e.g., 24 weeks minus baseline) derived from the mixed model.

Outcome measures

Outcome measures
Measure
Arm I (Tracking Device, Limited Version of Device)
n=143 Participants
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the limited version of device app/website to get basic information related to their physical activity for 6 months.
Arm II (Tracking Device, Interactive-reward Based Device)
n=148 Participants
Patients receive educational handouts about physical activity and are encouraged to increase physical activity to at least 420 minutes per week. Patients wear physical activity tracking device daily and upload data at least once a week to the device app/website. Patients also access the full version of the interactive-reward based device app/website to see their activity, earn activity points, see other's activity, and interact with other patients for 6 months.
Physiologic Cost Index (PCI)
0.6 beats per meter
Standard Deviation 0.3
0.54 beats per meter
Standard Deviation 0.29

SECONDARY outcome

Timeframe: Baseline up to 48 weeks post intervention

Markers of Cardiometabolic health include blood pressure, body mass index, waist to height ration, fasting insulin, glucose, and lipid levels. Differences in these markers between randomized groups and the effects of group assignment on changes over time will be evaluated.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline up to 48 weeks post intervention

Markers of an Inflammatory state include High sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor alpha. Differences in these markers between groups and the effects of group assignment on changes over time will be evaluated.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline up to 48 weeks post intervention

Will be assessed using Pediatric Quality of Life (PedsQL) 4.0 Generic Core Scale. The 23-item PedsQL Generic Core Scales were designed to measure the core dimensions of health as delineated by the World Health Organization, as well as role (school) functioning. Scores range from 0-100, higher is better. There are four scales (Physical Functioning, Emotional Functioning, Social Functioning, and School Functioning). Emotional, Social and School Functioning can be combined to create a psychosocial summary (summed and divided by total number of items). Differences between groups and the effects of group assignment on changes over time will be evaluated.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline up to 48 weeks post intervention

Will be assessed using Pediatric Quality of Life Multidimensional Fatigue Scale. The PedsQL Multidimensional Fatigue Scale was designed as a generic symptom-specific instrument to measure fatigue in patients with acute and chronic health conditions as well as healthy school and community populations. It has three dimensions, general fatigue, sleep/rest fatigue and cognitive fatigue. Scores range from 0-100 and items are summed and divided by the total to get the mean. Differences between groups and the effects of group assignment on changes over time will be evaluated.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline up to 48 weeks post intervention

Will be assessed using parent report. Differences between groups and the effects of group assignment on changes over time will be evaluated.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Up to 48 weeks post intervention

Markers of cardiometabolic health include blood pressure, body mass index, waist to height ration, fasting insulin, glucose, and lipid levels. It will be determined if the effect of an interactive web-based physical activity intervention on markers of cardiometabolic health is mediated by changes in fitness among children and adolescents following treatment for acute lymphoblastic leukemia. A causal inference approach will evaluate whether group assignment results in an improved outcome in the presence of a lower PCI. This requires decomposing the averaged total effect into indirect and direct effects of group assignment of on the cardiometabolic outcomes. A principal stratification method will be used that classifies participants into strata based on their performance on the PCI (mediator variable) for each group of the randomized intervention. Mediation analyses would then be based on intent-to-treat effects of group assignment on cardiometabolic health outcome within each strata.

Outcome measures

Outcome data not reported

Adverse Events

Arm I (Tracking Device, Limited Version of Device)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm II (Tracking Device, Interactive-reward Based Device)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Results Reporting Coordinator

Children's Oncology Group

Phone: 6262411500

Results disclosure agreements

  • Principal investigator is a sponsor employee Must obtain prior Sponsor approval
  • Publication restrictions are in place

Restriction type: OTHER